KERYX BIOPHARMACEUTICALS INC 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Nov 14, 2016
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2016-11-09$4.99/sh−1,559$7,779→ 254,647 total
Footnotes (2)
- [F1]Sale of a total of 1,559 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 5,000 shares of restricted stock on November 8, 2016. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 172,864 shares of restricted stock.